Cytotoxic Chemotherapy in Advanced Pancreatic Cancer.
Hematol Oncol Clin North Am
; 36(5): 1011-1018, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-36154782
Advanced pancreatic cancer remains one of the deadliest malignancies in 2022. Although there has been significant progress in treatment options with improved outcomes in many cancers, this growth has been slow in pancreatic cancer. This article examines specific components of approved first- and second-line therapies for advanced pancreatic cancer treatment and their effectiveness and concludes with a brief exploration of future directions for targeted therapies.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
Limits:
Humans
Language:
En
Journal:
Hematol Oncol Clin North Am
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2022
Document type:
Article
Country of publication:
Estados Unidos